Abstract
Introduction
During aging, dysregulated immune functions occur contributing to increased susceptibility to morbidity and mortality. However, these dysregulations are normally counterbalanced by continuous adaptation of the body to the deteriorative changes occurring over time. These adaptive changes well occur in healthy centenarians.
Discussion
Both innate (natural) and adaptive (acquired) immune responses decline with advancing age. Natural killer (NK) and natural killer T (NKT) cell cytotoxicity, representing one of best models of innate immune response, decreases in aging as well as interferon-γ (IFN-γ) production by both activated types of cells. Both NK and NKT cell cytotoxicity and IFN-γ production increase in very old age with respect to normal aging, especially by NKT cells bearing TCRγδ. The role played by zinc and metallothioneins (MT) is crucial because this affects NK and NKT cell development, maturation, and functions. In particular, some MT polymorphisms are involved in maintaining innate immune response and intracellular zinc ion availability in aging with thus a role of MT genetic background to escape some age-related diseases with subsequent healthy aging and longevity.
Similar content being viewed by others
References
Pawelec G. Immunosenescence: impact in the young as well as the old? Mech Ageing Dev. 1999;108:1–7. doi:10.1016/S0047-6374(99)00010-X.
Paolisso G, Barbieri M, Bonafe M, Franceschi C. Metabolic age modelling: the lesson from centenarians. Eur J Clin Invest. 2000;30:888–94. doi:10.1046/j.1365-2362.2000.00729.x.
Taniguchi M, Seino K, Nakayama T. The NKT cell system: bridging innate and acquired immunity. Nat Immunol. 2003;4:1164–5. doi:10.1038/ni1203-1164.
DelaRosa O, Pawelec G, Peralbo E, Wikby A, Mariani E, Mocchegiani E, et al. Immunological biomarkers of ageing in man: changes in both innate and adaptive immunity are associated with health and longevity. Biogerontology. 2006;7:471–81. doi:10.1007/s10522-006-9062-6.
Franceschi C, Monti D, Sansoni P, Cossarizza A. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today. 1995;16:12–6. doi:10.1016/0167-5699(95)80064-6.
Rink L, Haase H. Zinc homeostasis and immunity. Trends Immunol. 2007;28:1–4. doi:10.1016/j.it.2006.11.005.
Prasad AS. Zinc: Mechanisms of Host Defense. J Nutr. 2007;137:1345–9.
Mocchegiani E, Muzzioli M, Giacconi R. Zinc and immunoresistance to infection in aging: new biological tools. Trends Pharmacol Sci. 2000;21:205–8. doi:10.1016/S0165-6147(00)01476-0.
Mocchegiani E, Costarelli L, Giacconi R, Cipriano C, Muti E, Malavolta M. Zinc-binding proteins (metallothionein and alpha-2 macroglobulin) and immunosenescence. Exp Gerontol. 2006;41:1094–107. doi:10.1016/j.exger.2006.08.010.
Davis SR, Cousins RJ. Metallothionein expression in animals: a physiological perspective on function. J Nutr. 2000;130:1085–8.
Sansoni P, Vescovini R, Fagnoni F, Biasini C, Zanni F, Zanlari L, et al. The immune system in extreme longevity. Exp Gerontol. 2008;43:61–5. doi:10.1016/j.exger.2007.06.008.
Mocchegiani E, Giacconi R, Muti E, Cipriano C, Costarelli L, Tesei S, et al. Zinc-bound metallothioneins and immune plasticity: lessons from very old mice and humans. Immun Ageing. 2007;4:1–7. doi:10.1186/1742-4933-4-1.
Liuzzi JP, Lichten LA, Rivera S, Blanchard RK, Aydemir TB, Knutson MD, et al. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci U S A. 2005;102:6843–8. doi:10.1073/pnas.0502257102.
Mocchegiani E, Giacconi R, Muti E, Rogo C, Bracci M, Muzzioli M, et al. Zinc, immune plasticity, aging, and successful aging: role of metallothionein. Ann NY Acad Sci U S A. 2004;1019:127–34. doi:10.1196/annals.1297.023.
Budzynski W, Radzikowski C. Cytotoxic cells in immunodeficient athymic mice. Immunopharmacol Immunotoxicol. 1994;16:319–46. doi:10.3109/08923979409007097.
Lanier LL, Yu G, Phillips JH. Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells. Nature. 1989;342:803–5. doi:10.1038/342803a0.
Nakazawa T, Agematsu K, Yabuhara A. Later development of Fas ligand-mediated cytotoxicity as compared with granule-mediated cytotoxicity during the maturation of natural killer cells. Immunology. 1997;92:180–7. doi:10.1046/j.1365-2567.1997.00343.x.
Griffiths GM. Endocytosing the death sentence. J Cell Biol. 2003;160:155–6. doi:10.1083/jcb.200212143.
Trapani JA. Dual mechanisms of apoptosis induction by cytotoxic lymphocytes. Int Rev Cytol. 1998;182:111–92. doi:10.1016/S0074-7696(08)62169-5.
Solana R, Mariani E. NK and NK/T-cells in human senescence. Vaccine. 2000;18:1613–20. doi:10.1016/S0264-410X(99)00495-8.
Albright JW, Albright JF. Age-associated impairment of murine natural killer activity. Proc Natl Acad Sci U S A. 1983;80:6371–5. doi:10.1073/pnas.80.20.6371.
Kutza J, Murasko DM. Age-associated decline in IL-2 and IL-12 induction of LAK cell activity of human PBMC samples. Mech Ageing Dev. 1996;90:209–22. doi:10.1016/0047-6374(96)01772-1.
Mariani E, Roda P, Mariani AR, Vitale M, Degrassi A, Papa S, et al. Age-associated changes in CD8+ and CD16+ cell reactivity: clonal analysis. Clin Exp Immunol. 1990;81:479–84.
Ogata K, Yokose N, Tamura H, An E, Nakamura K, Dan K, et al. Natural killer cells in the late decades of human life. Clin Immunol Immunopathol. 1997;84:269–75. doi:10.1006/clin.1997.4401.
Mocchegiani E, Muzzioli M, Giacconi R, Cipriano C, Gasparini N, Franceschi C, et al. Metallothioneins/PARP-1/IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supply. Mech Ageing Dev. 2003;124:459–68. doi:10.1016/S0047-6374(03)00023-X.
Sansoni P, Brianti V, Fagnoni F, Snelli G, Marcato A, Passeri G, et al. NK cell activity and T-lymphocyte proliferation in healthy centenarians. Ann NY Acad Sci U S A. 1992;663:505–7. doi:10.1111/j.1749-6632.1992.tb38717.x.
Mariani E, Ravaglia G, Forti P, Meneghetti A, Tarozzi A, Maioli F, et al. Vitamin D, thyroid hormones and muscle mass influence natural killer (NK) innate immunity in healthy nonagenarians and centenarians. Clin Exp Immunol. 1999;116:19–27. doi:10.1046/j.1365-2249.1999.00855.x.
Borrego F, Alonso MC, Galiani MD, Carracedo J, Ramirez R, Ostos B, et al. NK phenotypic markers and IL2 response in NK cells from elderly people. Exp Gerontol. 1999;34:253–65. doi:10.1016/S0531-5565(98)00076-X.
Krishnaraj R. Senescence and cytokines modulate the NK cell expression. Mech Ageing Dev. 1997;96:89–101. doi:10.1016/S0047-6374(97)00045-6.
Pawelec G, Solana R, Remarque E, Mariani E. Impact of aging on innate immunity. J Leukoc Biol. 1998;64:703–12.
Mariani E, Monaco MC, Cattini L, Sinoppi M, Facchini A. Distribution and lytic activity of NK cell subsets in the elderly. Mech Ageing Dev. 1994;76:177–87. doi:10.1016/0047-6374(94)91592-X.
Lutz CT, Moore MB, Bradley S, Shelton BJ, Lutgendorf SK. Reciprocal age related change in natural killer cell receptors for MHC class I. Mech Ageing Dev. 2005;126:722–31. doi:10.1016/j.mad.2005.01.004.
Abedina S, Michel JJ, Lemster B, Vallejo AN. Diversity of NKR expression in aging T cells and in T cells of the aged: the new frontier into the exploration of protective immunity in the elderly. Exp Gerontol. 2005;40:537–48. doi:10.1016/j.exger.2005.04.012.
Mariani E, Meneghetti A, Formentini I, Neri S, Cattini L, Ravaglia G, et al. Different rates of telomere shortening and telomerase activity reduction in CD8 T and CD16 NK lymphocytes with ageing. Exp Gerontol. 2003;38:653–9. doi:10.1016/S0531-5565(03)00058-5.
Rink L, Cakman I, Kirchner H. Altered cytokine production in the elderly. Mech Ageing Dev. 1998;102:199–209. doi:10.1016/S0047-6374(97)00153-X.
Mariani E, Meneghetti A, Neri S, Ravaglia G, Forti P, Cattini L, et al. Chemokine production by natural killer cells from nonagenarians. Eur J Immunol. 2002;32:1524–9. doi:10.1002/1521-4141(200206)32:6<1524::AID-IMMU1524>3.0.CO;2-E.
Provinciali M, Muzzioli M, Fabris N. Timing of appearance and disappearance of IFN and IL-2 induced natural immunity during ontogenetic development and aging. Exp Gerontol. 1989;24:227–36. doi:10.1016/0531-5565(89)90014-4.
Trapani JA, Smyth MJ. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol. 2002;2:735–47. doi:10.1038/nri911.
Mariani E, Sgobbi S, Meneghetti A, Tadolini M, Tarozzi A, Sinoppi M, et al. Perforins in human cytolytic cells: the effect of age. Mech Ageing Dev. 1996;92:195–209. doi:10.1016/S0047-6374(96)01829-5.
Rukavina D, Laskarin G, Rubesa G, Strbo N, Bedenicki I, Manestar D, et al. Age-related decline of perforin expression in human cytotoxic T lymphocytes and natural killer cells. Blood. 1998;92:2410–20.
Krishnaraj R. Negative modulation of human NK cell activity by purinoceptors. 2. Age-associated, gender-specific partial loss of sensitivity to ATP. Cell Immunol. 1992;144:11–21. doi:10.1016/0008-8749(92)90221-A.
Franceschi C, Motta L, Valensin S, Rapisarda R, Franzone A, Berardelli M, et al. Do men and women follow different trajectories to reach extreme longevity? Italian Multicenter Study on Centenarians (IMUSCE). Aging (Milano). 2002;12:77–84.
Krishnaraj R, Bhooma T. Cytokine sensitivity of human NK cells during immunosenescence. 2. IL 2-induced interferon gamma secretion. Immunol Lett. 1996;50:59–63. doi:10.1016/0165-2478(96)02519-9.
Argentati K, Bartozzi B, Bernardini G, Di Stasio G, Provinciali M. Induction of natural killer cell activity and perforin and granzyme B gene expression following continuous culture of short pulse with interleukin-12 in young and old mice. Eur Cytokine Netw. 2000;11:59–66.
Provinciali M, Di Stefano G, Stronati S, Fabris N. Generation of human lymphokine-activated killer cells following an IL-2 pulse in elderly cancer patients. Cytokine. 1998;10:132–9. doi:10.1006/cyto.1997.0265.
Schwartz RN, Stover L, Dutcher J. Managing toxicities of high-dose interleukin-2. Oncology. 2002;16:11–20.
Mocchegiani E, Santarelli L, Costarelli L, Cipriano C, Muti E, Giacconi R, et al. Plasticity of neuroendocrine-thymus interactions during ontogeny and ageing: role of zinc and arginine. Ageing Res Rev. 2006;5:281–309. doi:10.1016/j.arr.2006.06.001.
Haase H, Mocchegiani E, Rink L. Correlation between zinc status and immune function in the elderly. Biogerontology. 2006;7:421–8. doi:10.1007/s10522-006-9057-3.
Godfrey DI, Berzins SP. Control points in NKT-cell development. Nat Immunol. 2007;7:505–18. doi:10.1038/nri2116.
Davodeau F, Peyrat MA, Necker A, Dominici R, Blanchard F, Leget C, et al. Close phenotypic and functional similarities between human and murine alphabeta T-cells expressing invariant TCR alpha-chains. J Immunol. 1997;158:5603–11.
Makino Y, Kanno R, Ito T, Higashino K, Taniguchi M. Predominant expression of invariant V alpha 14+ TCR alpha chain in NK1.1+ T-cell populations. Int Immunol. 1995;7:1157–61. doi:10.1093/intimm/7.7.1157.
Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H. The regulatory role of Valpha14 NKT-cells in innate and acquired immune response. Annu Rev Immunol. 2003;21:483–513. doi:10.1146/annurev.immunol.21.120601.141057.
Brigl M, Brenner MB. CD1: antigen presentation and T-cell function. Annu Rev Immunol. 2004;22:817–90. doi:10.1146/annurev.immunol.22.012703.104608.
Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T-cells: development, specificity, and function. Annu Rev Immunol. 1997;15:535–62. doi:10.1146/annurev.immunol.15.1.535.
Mattner J, Debord KL, Ismail N, Goff RD, Cantu C 3 rd, Zhou D, et al. Exogenous and endogenous glycolipid antigens activate NKT-cells during microbial infections. Nature. 2005;434:525–9. doi:10.1038/nature03408.
Lee PT, Benlagha K, Teyton L, Bendelac A. Distinct functional lineages of human V(alpha) 24 natural killer T-cells. J Exp Med. 2002;195:637–41. doi:10.1084/jem.20011908.
D'Andrea A, Goux D, De Lalla C, Koezuka Y, Montagna D, Moretta A, et al. Neonatal invariant Valpha24+ NKT lymphocytes are activated memory cells. Eur J Immunol. 2000;30:1544–50. doi:10.1002/1521-4141(200006)30:6<1544::AID-IMMU1544>3.0.CO;2-I.
Sandberg JK, Bhardwaj N, Nixon DF. Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Valpha24 NKT cell compartment. Eur J Immunol. 2003;33:588–96. doi:10.1002/eji.200323707.
Emoto M, Kaufmann SH. Liver NKT cells: an account of heterogeneity. Trends Immunol. 2003;24:364–9. doi:10.1016/S1471-4906(03)00162-5.
Biron CA, Brossay L. NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol. 2001;13:458–64. doi:10.1016/S0952-7915(00)00241-7.
Ohteki T, MacDonald HR. Major histocompatibility complex class I related molecules control the development of CD4+8- and CD4–8- subsets of natural killer 1.1+ T cell receptor-alpha/beta+ cells in the liver of mice. J Exp Med. 1994;180:699–704. doi:10.1084/jem.180.2.699.
Poccia F, Gougeon ML, Bonneville M, Lopez-Botet M, Moretta A, Battistini L, et al. Innate T-cell immunity to nonpeptidic antigens. Immunol Today. 1998;19:253–6. doi:10.1016/S0167-5699(98)01266-3.
Inui T, Nakagawa R, Ohkura S, Habu Y, Koike Y, Motoki K, et al. Age-associated augmentation of the synthetic ligand- mediated function of mouse NK1.1 ag(+) T cells: their cytokine production and hepatotoxicity in vivo and in vitro. J Immunol. 2002;169:6127–32.
Abo T, Kawamura T, Watanabe H. (Physiological responses of extrathymic T cells in the liver. Immunol Rev. 2000;174:135–49. doi:10.1034/j.1600-0528.2002.017415.x.
Tsukahara A, Seki S, Iiai T, Moroda T, Watanabe H, Suzuki S, et al. Mouse liver T cells: their change with aging and in comparison with peripheral T cells. Hepatology. 1997;26:301–9. doi:10.1002/hep. 510260208.
DelaRosa O, Tarazona R, Casado JG, Alonso C, Ostos B, Pena J, et al. Valpha24+ NKT cells are decreased in elderly humans. Exp Gerontol. 2002;37:213–7. doi:10.1016/S0531-5565(01)00186-3.
Jing Y, Gravenstein S, Chaganty NR, Chen N, Lyerly KH, Joyce S, et al. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood. Exp Gerontol. 2007;42:719–32. doi:10.1016/j.exger.2007.01.009.
Araujo LM, Lefort J, Nahori MA, Diem S, Zhu R, Dy M, et al. Exacerbated Th2-mediated airway inflammation and hyperresponsiveness in autoimmune diabetes-prone NOD mice: a critical role for CD1d-dependent NKT cells. Eur J Immunol. 2004;34:327–35. doi:10.1002/eji.200324151.
Cui J, Shin T, Kawano T, Sato H, Kondo E, Toura I, et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science. 1997;278:1623–6. doi:10.1126/science.278.5343.1623.
Mocchegiani E, Giacconi R, Cipriano C, Gasparini N, Bernardini G, Malavolta M, et al. The variations during the circadian cycle of liver CD1d-unrestricted NK1.1+TCRγδ+ cells lead to successful aging. Role of metallothioneins/IL-6/gp130/PARP-1 interplay in very old mice. Exp Gerontol. 2004;39:775–88. doi:10.1016/j.exger.2004.01.014.
Miyaji C, Watanabe H, Toma H, Akisaka M, Tomiyama K, Sato Y, et al. Functional alteration of granulocytes, NK cells, and natural killer T cells in centenarians. Hum Immunol. 2000;61:908–16. doi:10.1016/S0198-8859(00)00153-1.
Emoto M, Miyamoto M, Emoto Y, Zerrahn J, Kaufmann SH. A critical role of T-cell receptor gamma/delta cells in antibacterial protection in mice early in life. Hepatology. 2001;33:887–93. doi:10.1053/jhep. 2001.23504.
Watanabe H, Miyaji C, Kawachi Y, Iiai T, Ohtsuka K, Iwanage T, et al. Relationships between intermediate TCR cells and NK1.1+ T cells in various immune organs. NK1.1+ T cells are present within a population of intermediate TCR cells. J Immunol. 1995;155:2972–83.
Argentati K, Re F, Donnini A, Tucci MG, Franceschi C, Bartozzi B, et al. Numerical and functional alterations of circulating gammadelta T lymphocytes in aged people and centenarians. J Leukoc Biol. 2002;72:65–71.
Colonna-Romano G, Potestio M, Aquino A, Candore G, Lio D, Caruso C. Gamma/delta T lymphocytes are affected in the elderly. Exp Gerontol. 2002;37:205–11. doi:10.1016/S0531-5565(01)00185-1.
Chandra RK. (Nutrition and the immune system from birth to old age. Eur J Clin Nutr. 2002;56:S73–6. doi:10.1038/sj.ejcn.1601492.
Muzzioli M, Stecconi R, Moresi R, Provinciali M. Zinc improves the development of human CD34+ cell progenitors towards NK cells and increases the expression of GATA-3 transcription factor in young and old ages. Biogerontology. 2009. doi:10.1007/s10522-008-9201-3.
Mocchegiani E, Muzzioli M, Cipriano C, Giacconi R. Zinc, T-cell pathways, aging: role of metallothioneins. Mech Ageing Dev. 1998;106:183–204. doi:10.1016/S0047-6374(98)00115-8.
Mocchegiani E, Santarelli L, Muzzioli M, Fabris N. Reversibility of the thymic involution and of age-related peripheral immune dysfunctions by zinc supplementation in old mice. Int J Immunopharmacol. 1995;17:703–18. doi:10.1016/0192-0561(95)00059-B.
Mariani E, Neri S, Cattini L, Mocchegiani E, Malavolta M, Dedoussis GV, et al. Effect of zinc supplementation on plasma IL-6 and MCP-1 production and NK cell function in healthy elderly: interactive influence of +647 MT1a and -174 IL-6 polymorphic alleles. Exp Gerontol. 2008;43:462–71. doi:10.1016/j.exger.2007.12.003.
Mocchegiani E, Malavolta M, Muti E, Costarelli L, Cipriano C, Piacenza F, et al. Zinc, metallothioneins and longevity: interrelationships with niacin and selenium. Curr Pharm Des. 2008;14:2719–32. doi:10.2174/138161208786264188.
Cipriano C, Malavolta M, Costarelli L, Giacconi R, Muti E, Gasparini N, et al. Polymorphisms in MT1a gene coding region are associated with longevity in Italian Central female population. Biogerontology. 2006;7:357–65. doi:10.1007/s10522-006-9050-x.
Giacconi R, Bonfigli AR, Testa R, Sirolla C, Cipriano C, Marra M, et al. +647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications. Mol Genet Metab. 2008;94:98–104. doi:10.1016/j.ymgme.2007.12.006.
Giacconi R, Muti E, Malavolta M, Cipriano C, Costarelli L, Bernardini G, et al. The +838 C/G MT2A polymorphism, metals, and the inflammatory/immune response in carotid artery stenosis in elderly people. Mol Med. 2007;13:388–95. doi:10.2119/2007-00045.Giacconi.
Giacconi R, Cipriano C, Muti E, Costarelli L, Maurizio C, Saba V, et al. Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc. Biogerontology. 2005;6:407–13. doi:10.1007/s10522-005-4907-y.
Giacconi R, Cipriano C, Albanese F, Boccoli G, Saba V, Olivieri F, et al. The -174G/C polymorphism of IL- 6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing. Exp Gerontol. 2004;39:621–8. doi:10.1016/j.exger.2003.12.013.
Cipriano C, Caruso C, Lio D, Giacconi R, Malavolta M, Muti E, et al. The -308G/A polymorphism of TNF-alpha influences immunological parameters in old subjects affected by infectious diseases. Int J Immunogenet. 2005;32:13–8. doi:10.1111/j.1744-313X.2005.00490.x.
Mocchegiani E, Giacconi R, Costarelli L, Muti E, Cipriano C, Tesei S, et al. Zinc deficiency and IL-6–174G/C polymorphism in old people from different European countries: effect of zinc supplementation. ZINCAGE study. Exp Gerontol. 2008;43:433–44. doi:10.1016/j.exger.2008.01.001.
Kovalovsky D, Uche OU, Eladad S, Hobbs RM, Yi W, Alonzo E, et al. The BTB-zinc finger transcriptional regulator, PLZF, controls the development of iNKT cell effector functions. Nat Immunol. 2008;9:1055–64. doi:10.1038/ni.1641.
Mycko MP, Ferrero I, Wilson A, Jiang W, Bianchi T, Trumpp A, et al. Selective requirement for c-Myc at an early stage of V(alpha) 14i NKT cell development. J Immunol. 2009;182:4641–8. doi:10.4049/jimmunol.0803394.
Cipriano C, Giacconi R, Muzzioli M, Gasparini N, Orlando F, Corradi A, et al. Metallothionein (I + II) confers, via c-myc, immune plasticity in oldest mice: model of partial hepatectomy/liver regeneration. Mech Ageing Dev. 2003;124:877–86. doi:10.1016/S0047-6374(03)00146-5.
Mocchegiani E, Costarelli L, Giacconi R, Cipriano C, Muti E, Tesei S, et al. Nutrient-gene interaction in ageing and successful ageing. A single nutrient (zinc) and some target genes related to inflammatory/immune response. Mech Ageing Dev. 2006;127:517–25. doi:10.1016/j.mad.2006.01.010.
Acknowledgments
This study was supported by INRCA and 6th European Framework (Project ZINCAGE n. FOOD-CT-2004-506850, Coordinator: E. Mocchegiani).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mocchegiani, E., Giacconi, R., Cipriano, C. et al. NK and NKT Cells in Aging and Longevity: Role of Zinc and Metallothioneins. J Clin Immunol 29, 416–425 (2009). https://doi.org/10.1007/s10875-009-9298-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-009-9298-4